Metalaxyl 50% WP: Disease Fit and Product Selection

Metalaxyl 50% WP should be evaluated against a diagnosed disease problem, not simply a request for a “strong fungicide.” The useful starting questions are the pathogen, crop, intended application route, local resistance situation and approved product label. Only then can a buyer decide whether the listed formulation belongs in the proposed disease-management program.

Averstar lists metalaxyl 50% WP as a sourcing option for professional buyers. This guide explains the product description and the questions that should accompany an inquiry. It does not assign a universal application rate, crop authorization or treatment interval to that catalogue entry.

Quick answer: Confirm an appropriate disease target and local label, distinguish metalaxyl from metalaxyl-M, review the WP formulation, and ask how resistance management will be addressed. A percentage on the package is a concentration statement, not a field dosage or proof that a product fits every disease.

Start with the disease, not the symptom

The Fungicide Resistance Action Committee's phenylamide guidance places metalaxyl in the phenylamide family and FRAC Group 4. It describes activity directed at oomycete pathogens, including groups associated with downy mildews, Phytophthora and Pythium diseases. The same guidance identifies substantial resistance concerns within this mode-of-action group.

For product selection, that means the disease name matters. A complaint about leaf damage, poor emergence or root decline does not by itself identify the cause. Ask the crop adviser for the diagnosis or the evidence still needed to establish it. Avoid promising control from a photograph alone, especially when the buyer has not identified the crop or production conditions.

Write the suspected or confirmed pathogen separately from the symptom description. If the diagnosis is provisional, label it as provisional in the inquiry. That allows the supplier and local reviewer to discuss product suitability without converting uncertainty into a confident disease-control claim.

The crop disease control product brief can help organize the crop, target, production system and application requirements. Include the destination country early, because a technically relevant ingredient still needs an appropriate authorized product and use in that market.

Keep metalaxyl and metalaxyl-M distinct

FRAC lists metalaxyl and metalaxyl-M, also called mefenoxam, as separate active-ingredient names within Group 4. Keep the exact name in the quotation, specification, certificate of analysis and label. Do not shorten both names to “metalaxyl” in a purchase order, or assume their products can be exchanged at the same use rate.

Averstar also has combination-product listings containing metalaxyl-M. Those are separate configurations, with their own ingredient concentrations and formulation descriptions. Comparing them with a single-active metalaxyl 50% WP requires more than comparing the largest number in the title. Ask what each ingredient contributes and whether the proposed product is appropriate for the same labelled use.

Create separate inquiry lines for separate configurations. Record the full active-ingredient names, concentrations, formulation code and intended application route for each. This makes it easier to spot a substitution before artwork, samples or commercial quantities are prepared.

What 50% WP tells the buyer

WP means wettable powder. University of Georgia Extension's formulation guide distinguishes a wettable powder, which forms a suspension in water, from a soluble powder. It explains the need for agitation to prevent settling. Follow the actual product's label for preparation and equipment instructions rather than treating those general characteristics as a complete mixing procedure.

Confirm the concentration basis in the product specification. If 50% is stated as mass by mass, the calculated equivalent is 500 g of active ingredient per kilogram of formulated product. That describes product composition only. It is not a recommendation for the amount to add to water or apply to an area, and it should not be compared directly with a g/L liquid without understanding the different units.

For a sample review, ask the laboratory and technical reviewer to agree the relevant physical and chemical tests, methods and limits. Put the sample identifier and specification revision in the request. A generic statement that the powder “looks fine” does not resolve questions about the agreed formulation requirements.

Ask about the final packaging, moisture protection, closure and storage instructions for the proposed commercial configuration. Request a safety data sheet and the applicable label before preparing handling guidance for customers. The pesticide sample evaluation plan provides a practical way to organize the test request.

Ask the resistance question before ordering

FRAC describes cross-resistance among phenylamides and recommends preventive use. For foliar applications, its guidance calls for a pre-packed mixture with an unrelated effective partner within a sound management program. Consequently, a buyer should not position a single-active listing as a universal standalone foliar recommendation. The locally authorized use and resistance strategy need explicit review.

Changing from one Group 4 ingredient to another is not a change to a different mode of action. Ask the local adviser what is known about the target pathogen's sensitivity and what role, if any, the proposed product should have. Record that discussion before developing distributor sales material or recommending a seasonal supply program.

Do not infer that a named mixture automatically solves resistance. The adviser needs the actual partner, intended target, approved use and local situation. A catalogue comparison is useful for narrowing questions; it cannot determine whether a particular combination is effective against the pathogen in a customer's field.

For repeat orders, review whether the crop program or target problem has changed since the previous purchase. A familiar product name should not substitute for updated information from the customer. Keep product selection, approved-use confirmation and commercial ordering as connected but separate decisions.

A metalaxyl product selection brief

Use this proposed checklist when requesting technical and commercial information. The suggested questions do not establish a universal testing or registration requirement.

• Disease identity: Information to provide or request: Diagnosed pathogen, or clearly identified uncertainty.
• Crop context: Information to provide or request: Crop, production system and intended treatment route.
• Product identity: Information to provide or request: Metalaxyl 50% WP, with the concentration basis confirmed.
• Market fit: Information to provide or request: Destination country and exact approved product label.
• Resistance review: Information to provide or request: Local sensitivity information and adviser's program assessment.
• Sample scope: Information to provide or request: Specification revision, selected tests and laboratory responsibilities.
• Quality documents: Information to provide or request: Batch-linked COA, methods, units and relevant supporting records.
• Commercial format: Information to provide or request: Package size, label language, quantity and delivery requirements.

Assign each open question to the person able to answer it. The supplier can clarify the offered configuration and documents, the laboratory can define its test assignment, and the local reviewer can assess the permitted use. Purchasing can then compare offers on a more complete basis than price alone.

Request the exact product, with the exact use context

For a metalaxyl 50% WP inquiry, send the destination market, crop, disease target, intended treatment route and package requirements. Include any local label or registration specifications your reviewer needs to match. Contact Averstar with those details to discuss the product configuration, available documentation and quotation scope.